• Company
• CMV treatment Livtencity lands in Big 5 hospitals in KOR
• by Eo, Yun-Ho Jan 2, 2024 05:45am

• Policy
• Revising the PE exemption system… focuses on 'deferral'
• by Lee, Tak-Sun Jan 2, 2024 05:44am

• Company
• Celltrion merges and launches with founder’s son as leader
• by Kim, Jin-Gu Dec 29, 2023 05:40am

• Company
• K-similars set out to enter the global market
• by Son, Hyung-Min Dec 29, 2023 05:40am

• Policy
• Peramiflu shortages may require gov. intervention
• by Lee, Tak-Sun Dec 29, 2023 05:39am

• Company
• Integrated Celltrion launches with goal of 40T market cap
• by Kim, Jin-Gu Dec 29, 2023 05:39am

• Company
• Medytox submits BLA to FDA for its next-gen botulinum
• by Chon, Seung-Hyun Dec 29, 2023 05:39am

• Company
• Hugel Resolves to Retire 371,563 shares of its own stock
• by Nho, Byung Chul Dec 28, 2023 01:14pm

• Policy
• True Set, a triple hypertension therapy, to face generics
• by Lee, Tak-Sun Dec 28, 2023 06:02am

• Company
• Tezspire lands in Korea…joins 6-way race
• by Dec 28, 2023 06:02am